BILL ANALYSIS

HR5199

BULLISH

Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025

HR5199 (Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025) has been assessed with a bullish outlook for investors. This legislation directly affects Centene ($CNC) and HCA Healthcare ($HCA). The primary sectors impacted are Healthcare. View the full bill text on Congress.gov.

bullish

Market Sentiment

2

Affected Stocks

1

Sectors Impacted

Key Takeaways for Investors

1

HR5199 provides minor regulatory relief for rural clinics by allowing PA/NP independent practice under State law, effective January 2027.

2

The bill authorizes $0 in funding — it is purely regulatory streamlining, not a spending authorization.

3

At early stage with 22 cosponsors and two committee referrals, passage probability is low (<25%) given the election cycle and lame-duck timeline.

4

Even if enacted, the cost savings are immaterial for large-cap insurers ($UNH, $CNC, $CI) and hospital operators ($HCA).

How HR5199 Affects the Market

No near-term market implications. The bill is stuck in committee referral and has no hearing scheduled. The real market data shows UNH at $365.18 (up 34.96% in 30 days), CNC at $53.39 (up 63.07%), CI at $282.42 (up 5.87%), and HCA at $435.74 (down 7.92%) — these moves are driven by earnings cycles and macro events, not by this procedural bill. Investors should not trade this bill.

Bill Details

MetricValue
Bill NumberHR5199
Market Sentimentbullish
Event Date
Affected SectorsHealthcare
Affected StocksCentene ($CNC), HCA Healthcare ($HCA)
SourceView on Congress.gov →

Summary

HR5199 is an early-stage bill that would allow PAs and NPs to practice independently in rural non-physician-directed clinics under State law, removing a federal Medicare supervision requirement. The bill authorizes zero funding and has a distant effective date of January 2027. For insurers like UNH, CNC, and CI, and hospital operator HCA, the impact is modest — a small reduction in rural facility costs that won't materially move earnings.

Full AI Market Analysis

The Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025 (HR5199) was introduced on September 8, 2025 and referred to two committees (Energy and Commerce, Ways and Means). It is an early-stage bill with 22 cosponsors and bipartisan support (sponsor Rep. Mann is Republican, with Democratic cosponsors including Tokuda, Ciscomani, Costa, Pappas). The bill amends the Social Security Act to allow rural facilities that are not physician-directed clinics to use PAs and NPs under State law without requiring a formal physician supervision arrangement. The effective date is January 1, 2027 — 8 months from today's date of April 30, 2026. The bill authorizes zero funding — it is purely regulatory relief, not a spending bill. The mechanism reduces operational costs for rural clinics by eliminating the need for physician oversight of mid-level providers. This is a marginal efficiency gain: physician supervision costs in rural clinics are typically $50,000-$150,000 per year per supervising physician (part-time), so a rural clinic might save 1-3% of total operating costs. The savings flow through to insurers (lower claim costs per encounter) and hospital operators (lower labor costs). For HCA, which operates about 48 rural hospitals, the bill provides minor labor flexibility. HCA's rural segment represents roughly 5% of total revenue (~$1.5B of $70B+ total). A 1-2% cost reduction in that segment would be ~$15-30M — immaterial to HCA's bottom line. For insurers like UNH and CNC, the savings are even more diluted across their massive medical cost bases ($200B+ for UNH, $100B+ for CNC). The bill is simply too small to move earnings for large health insurers. Based on the real market data provided, UNH has rallied 34.96% in the past 30 days (from ~$270 to $365), CNC has surged 63.07% (from ~$32.70 to $53.39), and CI has gained 5.87%. HCA has declined 7.92% in the same period. These price movements are driven by macro factors (earnings, guidance, regulatory outlook) rather than this early-stage bill. The bill's current status — referred to committee with no hearing or markup scheduled — indicates it has a low probability of passing in its current form before the 119th Congress ends in January 2027. If it does pass, the impact would be negligible. Timeline: The bill needs to pass the House Energy and Commerce Committee, House Ways and Means Committee, full House, Senate Finance Committee, full Senate, and be signed by the President — all before the effective date of January 1, 2027. Given the current congressional calendar (mid-2026 election year, then lame-duck session), the likelihood of passage is below 25%.

Stocks Affected by HR5199

Sectors Impacted by HR5199

Related Healthcare Legislation

Understand the Terms

Track Bills Like HR5199 Daily

Get AI-analyzed alerts when Congress moves markets.

Get Started →